News Focus
News Focus
Followers 40
Posts 5751
Boards Moderated 0
Alias Born 04/12/2021

Re: None

Wednesday, 08/31/2022 1:11:41 AM

Wednesday, August 31, 2022 1:11:41 AM

Post# of 43
They have enough funding till late 2024, they have non-dilutive revenue and opportunities for more non-dilutive revenue, they have promising drugs in the pipeline that have exhibited safety and efficacy and they have a buyback in progress and charts which have completely consolidated: 1 month, 3 months, 6 months, 1 year and 5 year charts all ready to go. Perfect opportunity by any and all measures imo. From 31.83 to 1.46 in 18 months, down 97%:, Assets:Liabilities 3:1.

my posts are always theory and not financial advice

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAG News